5-HTP side effects and risks: what the science really says

5-HTP (5-hydroxytryptophan) is a serotonin precursor available as a dietary supplement, marketed to support mood, improve sleep and regulate appetite. Two opposing myths surround it: some claim it is a completely safe natural substance, while others portray it as frightening as a narcotic drug. In reality, 5-HTP side effects are specific, documented and largely dependent on dose and interactions.

Which 5-HTP side effects are clinically proven?

The most common side effects are gastrointestinal. In clinical trials using doses of 50–200 mg per day, nausea, abdominal pain, diarrhea and vomiting were observed in up to 30–40% of participants (Turner et al., 2006). In most cases, these symptoms subside when the dose is reduced or the supplement is taken with food, and they are not associated with serious toxicity.

As what science says about building muscle explains, gastrointestinal side effects from supplements often indicate a high dose rather than an inherent danger. The same rule applies to 5-HTP.

Less common but more serious side effects include:

• Drowsiness and dizziness — particularly with initial doses or at high doses.
• Headache — paradoxically, given that 5-HTP has been studied for migraine prevention.
• Changes in blood pressure — observed with long-term use at higher doses (Birdsall, 1998).

Does 5-HTP cause serotonin syndrome?

Serotonin syndrome is the most frequently cited concern surrounding 5-HTP — and this is where the myth is particularly persistent. Serotonin syndrome occurs when serotonergic activity rises excessively, with symptoms ranging from muscle twitching and sweating to life-threatening hyperthermia and seizures (Boyer & Shannon, 2005).

The reality is this: a single dose of 5-HTP does not cause serotonin syndrome in a healthy person. The danger arises when it is combined with other serotonergic substances:

• SSRI and SNRI antidepressants (fluoxetine, sertraline, venlafaxine and others)
• MAO inhibitors (including some natural remedies such as St. John’s wort)
• Triptans used to treat migraines
• Tramadol and some painkillers

If you take any of the medications listed above, using 5-HTP without consulting your doctor is contraindicated. This is not an exaggeration — it is an evidence-based recommendation.

Is 5-HTP as dangerous as the 1989 L-tryptophan scandal suggests?

Many people fear 5-HTP because of the 1989 outbreak of eosinophilia-myalgia syndrome (EMS) in the US, which affected thousands of L-tryptophan users and caused serious harm to their health. An epidemiological investigation found that EMS was caused by biological contamination in a batch from one Japanese manufacturer (Showa Denko K.K.) — not by L-tryptophan itself (Belongia et al., 1990).

5-HTP is a chemically different compound, synthesized through a different biosynthetic pathway and usually obtained from Griffonia simplicifolia seeds. Third-party certification (NSF, USP, Informed Sport) reduces the risk of contamination. Arnold says something that has long held true: good training and informed nutrition are the foundation, supplements are supplements — and their quality deserves attention.

Who is at risk when taking 5-HTP, and at what doses?

In clinical trials, 5-HTP has been shown to be generally safe for use for up to 12 weeks at doses of up to 300 mg per day (Birdsall, 1998). Research on longer-term use beyond 12 weeks is limited — which is why researchers do not recommend uninterrupted long-term use.

The following groups require particular attention:

• Pregnant and breastfeeding mothers — safety data are lacking, and the risk to the fetus is unknown.
• People with Parkinson’s disease — combining it with carbidopa may cause scleroderma-like skin reactions.
• People with liver failure — slower metabolism increases the risk of accumulation.
• Children and adolescents — clinical data for this age group are lacking.

The NIH Office of Dietary Supplements emphasizes that when using dietary supplements, you must always consider interactions with other substances and existing health conditions (NIH Office of Dietary Supplements).

A Cochrane systematic review of L-tryptophan and 5-HTP for depression found moderate evidence of short-term effectiveness, but highlighted the small size and short duration of the studies — and called for larger, more methodologically robust trials (Shaw et al., 2002).

Interestingly, one controlled study showed that 5-HTP helped people who were overweight reduce their calorie intake and supported a reduction in body weight by increasing satiety (Cangiano et al., 1992). As what to do with nut butter illustrates, L-tryptophan-rich foods and a well-chosen supplement can complement each other, but neither replaces a balanced diet.

Overall, 5-HTP is neither a miracle cure nor a toxic, banned substance. What’s new in supplement science consistently reveals the same pattern — the myth of absolute safety gives way to an evidence-based risk profile that is specific, manageable and dependent on the individual.

References

• Turner EH, Loftis JM, Blackwell AD (2006). Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacology & Therapeutics. 109(3):325-38. PMID: 16023217
• Birdsall TC (1998). 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Alternative Medicine Review. 3(4):271-80. PMID: 9727088
• Shaw K, Turner J, Del Mar C (2002). Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database Syst Rev. (1):CD003198. PMID: 12535404
• Boyer EW, Shannon M (2005). The serotonin syndrome. New England Journal of Medicine. 352(11):1112-20. PMID: 15784664
• Belongia EA, Hedberg CW, Gleich GJ, White KE, Mayeno AN, Loegering DA, Doepke LE, Schroeter AL, McGlave PB, Plumbo M (1990). An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. New England Journal of Medicine. 323(6):357-65. PMID: 2352546
• Cangiano C, Ceci F, Cascino A, Del Ben M, Laviano A, Muscaritoli M, Antonucci F, Rossi-Fanelli F (1992). Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. American Journal of Clinical Nutrition. 56(5):863-7. PMID: 1384197

Come work out! ArtGym